{"transactions":[{"id":3414,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":2368,"kind":"person","name":"BURNETT JOSEPH","position":1,"cik":"0001721010","reported_name":"BURNETT JOSEPH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Stock Options (right to buy)","published_at":"2026-09-03T22:22:12.000Z","date":"2026-09-02","kind":"exercise","planned":false,"acquired":false,"shares":12517,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Mr. Burnett paid the exercise price for the options in cash and has held all shares received upon exercise. No shares of stock were sold in connection with this transaction."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to this option vest as follows: (i) 20% of the total shares on the first anniversary of the grant date; (ii) 40% of the total shares on the second anniversary of the grant date; and (iii) 40% of the total shares on the third anniversary of the grant date. The grant date is August 15, 2019."}],"balance_after":61887,"derivative":{"exercise_price":3.47,"expiration_date":"2029-08-15","underlying":"Common Stock","underlying_shares":12517},"source":{"system":"sec-edgar","filing":"0001193125-26-382208","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1721010/000119312526382208/ownership.xml","form_type":"4"}},{"id":3413,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":2368,"kind":"person","name":"BURNETT JOSEPH","position":1,"cik":"0001721010","reported_name":"BURNETT JOSEPH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2026-09-03T22:22:12.000Z","date":"2026-09-02","kind":"exercise","planned":false,"acquired":true,"shares":12517,"price":3.47,"value":43433.99,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Mr. Burnett paid the exercise price for the options in cash and has held all shares received upon exercise. No shares of stock were sold in connection with this transaction."}],"balance_after":130720,"source":{"system":"sec-edgar","filing":"0001193125-26-382208","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1721010/000119312526382208/ownership.xml","form_type":"4"}},{"id":717630,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":2368,"kind":"person","name":"BURNETT JOSEPH","position":1,"cik":"0001721010","reported_name":"BURNETT JOSEPH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2026-07-02T20:05:15.000Z","date":"2026-06-30","kind":"grant","planned":false,"acquired":true,"shares":1361,"price":11.93,"value":16236.73,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of the Issuer's common stock pursuant to the Employee Stock Purchase Plan (\"ESPP\"), for the ESPP purchase period of January 1, 2026 through June 30, 2026. In accordance with the ESPP, these shares were purchased at the lesser of 85% of the fair market value on either the first day or last day of the purchase period."}],"balance_after":118203,"source":{"system":"sec-edgar","filing":"0001193125-26-294474","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000119312526294474/ownership.xml","form_type":"4"}},{"id":720955,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":2368,"kind":"person","name":"BURNETT JOSEPH","position":1,"cik":"0001721010","reported_name":"BURNETT JOSEPH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Stock Options (right to buy)","published_at":"2026-07-01T22:43:09.000Z","date":"2026-06-29","kind":"exercise","planned":true,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The options exercised and sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on June 11, 2025 in accordance with Rule 10b5-1."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to this option vest as follows: (i) one-third of the total shares on the first anniversary of the grant date; and (ii) the remaining two-thirds of the total shares ratably on a quarterly basis over the 2-year period immediately following the first anniversary of the grant date. The grant date is November 7, 2017."}],"balance_after":250000,"derivative":{"exercise_price":2.5,"expiration_date":"2027-11-07","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001193125-26-292932","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000119312526292932/ownership.xml","form_type":"4"}},{"id":720954,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":2368,"kind":"person","name":"BURNETT JOSEPH","position":1,"cik":"0001721010","reported_name":"BURNETT JOSEPH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2026-07-01T22:43:09.000Z","date":"2026-06-29","kind":"sale","planned":true,"acquired":false,"shares":20000,"price":19.38,"value":387600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The options exercised and sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on June 11, 2025 in accordance with Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average sales price per share. The shares were sold at prices ranging from $19.15 to $19.54. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":116842,"source":{"system":"sec-edgar","filing":"0001193125-26-292932","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000119312526292932/ownership.xml","form_type":"4"}},{"id":720953,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":2368,"kind":"person","name":"BURNETT JOSEPH","position":1,"cik":"0001721010","reported_name":"BURNETT JOSEPH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2026-07-01T22:43:09.000Z","date":"2026-06-29","kind":"exercise","planned":true,"acquired":true,"shares":20000,"price":2.5,"value":50000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The options exercised and sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on June 11, 2025 in accordance with Rule 10b5-1."}],"balance_after":136842,"source":{"system":"sec-edgar","filing":"0001193125-26-292932","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000119312526292932/ownership.xml","form_type":"4"}},{"id":730367,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":2368,"kind":"person","name":"BURNETT JOSEPH","position":1,"cik":"0001721010","reported_name":"BURNETT JOSEPH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Stock Options (right to buy)","published_at":"2026-06-22T20:05:05.000Z","date":"2026-06-17","kind":"exercise","planned":true,"acquired":false,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The options exercised and sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on June 11, 2025 in accordance with Rule 10b5-1."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares subject to this option vest as follows: (i) one-third of the total shares on the first anniversary of the grant date; and (ii) the remaining two-thirds of the total shares ratably on a quarterly basis over the 2-year period immediately following the first anniversary of the grant date. The grant date is November 7, 2017."}],"balance_after":270000,"derivative":{"exercise_price":2.5,"expiration_date":"2027-11-07","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001193125-26-277503","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000119312526277503/ownership.xml","form_type":"4"}},{"id":730366,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":2368,"kind":"person","name":"BURNETT JOSEPH","position":1,"cik":"0001721010","reported_name":"BURNETT JOSEPH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2026-06-22T20:05:05.000Z","date":"2026-06-17","kind":"sale","planned":true,"acquired":false,"shares":1843,"price":17.94,"value":33063.42,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The options exercised and sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on June 11, 2025 in accordance with Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents a weighted average sales price per share. The shares were sold at prices ranging from $17.75 to $18.08. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"These shares are owned directly by the Joseph M. Burnett Trust dated 10/20/2022 and indirectly by Joseph M. Burnett as trustee of the trust."}],"balance_after":191388,"source":{"system":"sec-edgar","filing":"0001193125-26-277503","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000119312526277503/ownership.xml","form_type":"4"}},{"id":730365,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":2368,"kind":"person","name":"BURNETT JOSEPH","position":1,"cik":"0001721010","reported_name":"BURNETT JOSEPH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2026-06-22T20:05:05.000Z","date":"2026-06-17","kind":"sale","planned":true,"acquired":false,"shares":60000,"price":17.79,"value":1067400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The options exercised and sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on June 11, 2025 in accordance with Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average sales price per share. The shares were sold at prices ranging from $17.35 to $18.15. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":116842,"source":{"system":"sec-edgar","filing":"0001193125-26-277503","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000119312526277503/ownership.xml","form_type":"4"}},{"id":730364,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":2368,"kind":"person","name":"BURNETT JOSEPH","position":1,"cik":"0001721010","reported_name":"BURNETT JOSEPH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2026-06-22T20:05:05.000Z","date":"2026-06-17","kind":"exercise","planned":true,"acquired":true,"shares":60000,"price":2.5,"value":150000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The options exercised and sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on June 11, 2025 in accordance with Rule 10b5-1."}],"balance_after":176842,"source":{"system":"sec-edgar","filing":"0001193125-26-277503","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000119312526277503/ownership.xml","form_type":"4"}},{"id":832104,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":2368,"kind":"person","name":"BURNETT JOSEPH","position":1,"cik":"0001721010","reported_name":"BURNETT JOSEPH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Stock Options (right to buy)","published_at":"2026-03-20T20:23:34.000Z","date":"2026-03-19","kind":"exercise","planned":false,"acquired":false,"shares":20942,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Mr. Burnett paid the exercise price for the options in cash and has held all shares received upon exercise. No shares of stock were sold in connection with this transaction."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to this option vest as follows: (i) 20% of the total shares on the first anniversary of the grant date; (ii) 40% of the total shares on the second anniversary of the grant date; and (iii) 40% of the total shares on the third anniversary of the grant date. The grant date is July 9, 2020."}],"balance_after":31414,"derivative":{"exercise_price":3.24,"expiration_date":"2030-07-09","underlying":"Common Stock","underlying_shares":20942},"source":{"system":"sec-edgar","filing":"0001193125-26-117695","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000119312526117695/ownership.xml","form_type":"4"}},{"id":832103,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":2368,"kind":"person","name":"BURNETT JOSEPH","position":1,"cik":"0001721010","reported_name":"BURNETT JOSEPH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2026-03-20T20:23:34.000Z","date":"2026-03-19","kind":"exercise","planned":false,"acquired":true,"shares":20942,"price":3.24,"value":67852.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Mr. Burnett paid the exercise price for the options in cash and has held all shares received upon exercise. No shares of stock were sold in connection with this transaction."}],"balance_after":116842,"source":{"system":"sec-edgar","filing":"0001193125-26-117695","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000119312526117695/ownership.xml","form_type":"4"}},{"id":841389,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":2368,"kind":"person","name":"BURNETT JOSEPH","position":1,"cik":"0001721010","reported_name":"BURNETT JOSEPH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Restricted Stock Units","published_at":"2026-03-16T18:51:25.000Z","date":"2026-03-12","kind":"exercise","planned":false,"acquired":false,"shares":84829,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. (\"CLPT\") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. (\"CLPT\") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. (\"CLPT\") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. (\"CLPT\") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."}],"balance_after":84828,"derivative":{"underlying":"Common Stock","underlying_shares":84829},"source":{"system":"sec-edgar","filing":"0001193125-26-108083","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000119312526108083/ownership.xml","form_type":"4"}},{"id":841388,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":2368,"kind":"person","name":"BURNETT JOSEPH","position":1,"cik":"0001721010","reported_name":"BURNETT JOSEPH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2026-03-16T18:51:25.000Z","date":"2026-03-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":43161,"price":11.53,"value":497646.33,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the amount of shares delivered to CLPT to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":95900,"source":{"system":"sec-edgar","filing":"0001193125-26-108083","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000119312526108083/ownership.xml","form_type":"4"}},{"id":841387,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":2368,"kind":"person","name":"BURNETT JOSEPH","position":1,"cik":"0001721010","reported_name":"BURNETT JOSEPH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2026-03-16T18:51:25.000Z","date":"2026-03-12","kind":"exercise","planned":false,"acquired":true,"shares":84829,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. (\"CLPT\") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."}],"balance_after":139061,"source":{"system":"sec-edgar","filing":"0001193125-26-108083","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000119312526108083/ownership.xml","form_type":"4"}},{"id":850749,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":2368,"kind":"person","name":"BURNETT JOSEPH","position":1,"cik":"0001721010","reported_name":"BURNETT JOSEPH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Restricted Stock Units","published_at":"2026-03-10T21:03:04.000Z","date":"2026-03-06","kind":"exercise","planned":false,"acquired":false,"shares":47407,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. (\"CLPT\") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. (\"CLPT\") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. (\"CLPT\") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. (\"CLPT\") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":47407},"source":{"system":"sec-edgar","filing":"0001193125-26-100364","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000119312526100364/ownership.xml","form_type":"4"}},{"id":850748,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":2368,"kind":"person","name":"BURNETT JOSEPH","position":1,"cik":"0001721010","reported_name":"BURNETT JOSEPH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2026-03-10T21:03:04.000Z","date":"2026-03-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":22709,"price":10,"value":227090.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the amount of shares delivered to CLPT to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":54232,"source":{"system":"sec-edgar","filing":"0001193125-26-100364","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000119312526100364/ownership.xml","form_type":"4"}},{"id":850747,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":2368,"kind":"person","name":"BURNETT JOSEPH","position":1,"cik":"0001721010","reported_name":"BURNETT JOSEPH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2026-03-10T21:03:04.000Z","date":"2026-03-06","kind":"exercise","planned":false,"acquired":true,"shares":47407,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. (\"CLPT\") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."}],"balance_after":76941,"source":{"system":"sec-edgar","filing":"0001193125-26-100364","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000119312526100364/ownership.xml","form_type":"4"}},{"id":858112,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":2368,"kind":"person","name":"BURNETT JOSEPH","position":1,"cik":"0001721010","reported_name":"BURNETT JOSEPH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Restricted Stock Units","published_at":"2026-03-05T21:48:17.000Z","date":"2026-03-03","kind":"exercise","planned":false,"acquired":false,"shares":26568,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. (\"CLPT\") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. (\"CLPT\") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. (\"CLPT\") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. (\"CLPT\") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."}],"balance_after":106273,"derivative":{"underlying":"Common Stock","underlying_shares":26568},"source":{"system":"sec-edgar","filing":"0001193125-26-094153","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000119312526094153/ownership.xml","form_type":"4"}},{"id":858111,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":2368,"kind":"person","name":"BURNETT JOSEPH","position":1,"cik":"0001721010","reported_name":"BURNETT JOSEPH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2026-03-05T21:48:17.000Z","date":"2026-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":9533,"price":8.84,"value":84271.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the amount of shares delivered to CLPT to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":29534,"source":{"system":"sec-edgar","filing":"0001193125-26-094153","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000119312526094153/ownership.xml","form_type":"4"}},{"id":858110,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":2368,"kind":"person","name":"BURNETT JOSEPH","position":1,"cik":"0001721010","reported_name":"BURNETT JOSEPH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2026-03-05T21:48:17.000Z","date":"2026-03-03","kind":"exercise","planned":false,"acquired":true,"shares":26568,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. (\"CLPT\") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."}],"balance_after":39067,"source":{"system":"sec-edgar","filing":"0001193125-26-094153","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000119312526094153/ownership.xml","form_type":"4"}},{"id":879417,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":2368,"kind":"person","name":"BURNETT JOSEPH","position":1,"cik":"0001721010","reported_name":"BURNETT JOSEPH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2026-02-26T21:07:49.000Z","date":"2026-02-25","kind":"sale","planned":true,"acquired":false,"shares":19951,"price":15.17,"value":302656.67,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of shares reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on June 11, 2025 in accordance with Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average sales price per share. The shares were sold at prices ranging from $15.15 to $15.25. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Reflects 934 shares previously owned by the Joseph M. Burnett Trust dated 10/20/2022 (the \"Trust\") which were transferred to the Reporting Person as direct ownership on February 6, 2026."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"These shares are owned directly by the Trust and indirectly by Joseph M. Burnett as trustee of the trust."}],"balance_after":193231,"source":{"system":"sec-edgar","filing":"0001193125-26-076586","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000119312526076586/ownership.xml","form_type":"4"}},{"id":893004,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":2368,"kind":"person","name":"BURNETT JOSEPH","position":1,"cik":"0001721010","reported_name":"BURNETT JOSEPH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Restricted Stock Units","published_at":"2026-02-19T21:07:33.000Z","date":"2026-02-17","kind":"grant","planned":false,"acquired":true,"shares":147275,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CLPT common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest as follows: (i) 20% of the total shares on February 17, 2027; (ii) 40% of the total shares on February 17, 2028; and (iii) 40% of the total shares on February 17, 2029."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest as follows: (i) 20% of the total shares on February 17, 2027; (ii) 40% of the total shares on February 17, 2028; and (iii) 40% of the total shares on February 17, 2029."}],"balance_after":147275,"derivative":{"underlying":"Common Stock","underlying_shares":147275},"source":{"system":"sec-edgar","filing":"0001193125-26-059357","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000119312526059357/ownership.xml","form_type":"4"}},{"id":929877,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":2368,"kind":"person","name":"BURNETT JOSEPH","position":1,"cik":"0001721010","reported_name":"BURNETT JOSEPH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2026-01-27T21:27:46.000Z","date":"2026-01-26","kind":"sale","planned":true,"acquired":false,"shares":2943,"price":15.57,"value":45822.51,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of shares reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on June 11, 2025 in accordance with Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average sales price per share. The shares were sold at prices ranging from $15.23 to $15.65. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are owned directly by the Joseph M. Burnett Trust dated 10/20/2022 and indirectly by Joseph M. Burnett as trustee of the trust."}],"balance_after":214116,"source":{"system":"sec-edgar","filing":"0001193125-26-024544","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000119312526024544/ownership.xml","form_type":"4"}},{"id":939983,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":2368,"kind":"person","name":"BURNETT JOSEPH","position":1,"cik":"0001721010","reported_name":"BURNETT JOSEPH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Stock Options (right to buy)","published_at":"2026-01-13T22:00:03.000Z","date":"2026-01-09","kind":"exercise","planned":true,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The options exercised and sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on June 11, 2025 in accordance with Rule 10b5-1."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to this option vest as follows: (i) one-third of the total shares on the first anniversary of the grant date; and (ii) the remaining two-thirds of the total shares ratably on a quarterly basis over the 2-year period immediately following the first anniversary of the grant date. The grant date is November 7, 2017."}],"balance_after":330000,"derivative":{"exercise_price":2.5,"expiration_date":"2027-11-07","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001193125-26-011866","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000119312526011866/ownership.xml","form_type":"4"}},{"id":939982,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":2368,"kind":"person","name":"BURNETT JOSEPH","position":1,"cik":"0001721010","reported_name":"BURNETT JOSEPH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2026-01-13T22:00:03.000Z","date":"2026-01-09","kind":"sale","planned":true,"acquired":false,"shares":20000,"price":16.12,"value":322400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The options exercised and sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on June 11, 2025 in accordance with Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average sales price per share. The shares were sold at prices ranging from $15.88 to $16.43. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":11565,"source":{"system":"sec-edgar","filing":"0001193125-26-011866","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000119312526011866/ownership.xml","form_type":"4"}},{"id":939981,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":2368,"kind":"person","name":"BURNETT JOSEPH","position":1,"cik":"0001721010","reported_name":"BURNETT JOSEPH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2026-01-13T22:00:03.000Z","date":"2026-01-09","kind":"exercise","planned":true,"acquired":true,"shares":20000,"price":2.5,"value":50000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The options exercised and sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on June 11, 2025 in accordance with Rule 10b5-1."}],"balance_after":31565,"source":{"system":"sec-edgar","filing":"0001193125-26-011866","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000119312526011866/ownership.xml","form_type":"4"}},{"id":950732,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":2368,"kind":"person","name":"BURNETT JOSEPH","position":1,"cik":"0001721010","reported_name":"BURNETT JOSEPH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2026-01-05T23:49:18.000Z","date":"2025-12-31","kind":"grant","planned":false,"acquired":true,"shares":254,"price":9.57,"value":2430.78,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of the Issuer's common stock pursuant to the Employee Stock Purchase Plan (\"ESPP\"), for the ESPP purchase period of July 1, 2025 through December 31, 2025. In accordance with the ESPP, these shares were purchased at the lesser of 85% of the fair market value on either the first day or last day of the purchase period."}],"balance_after":11565,"source":{"system":"sec-edgar","filing":"0001193125-26-002949","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000119312526002949/ownership.xml","form_type":"4"}},{"id":1019132,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":2368,"kind":"person","name":"BURNETT JOSEPH","position":1,"cik":"0001721010","reported_name":"BURNETT JOSEPH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2025-10-14T20:33:00.000Z","date":"2025-10-10","kind":"sale","planned":true,"acquired":false,"shares":300,"price":29.21,"value":8763.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of shares reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on June 11, 2025 in accordance with Rule 10b5-1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are owned directly by the Joseph M. Burnett Trust dated 10/20/2022 and indirectly by Joseph M. Burnett as trustee of the trust."}],"balance_after":217059,"source":{"system":"sec-edgar","filing":"0001193125-25-239077","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000119312525239077/ownership.xml","form_type":"4"}},{"id":1019131,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":2368,"kind":"person","name":"BURNETT JOSEPH","position":1,"cik":"0001721010","reported_name":"BURNETT JOSEPH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2025-10-14T20:33:00.000Z","date":"2025-10-10","kind":"sale","planned":true,"acquired":false,"shares":1981,"price":28.64,"value":56735.84,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of shares reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on June 11, 2025 in accordance with Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents a weighted average sales price per share. The shares were sold at prices ranging from $28.08 to $29.05. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are owned directly by the Joseph M. Burnett Trust dated 10/20/2022 and indirectly by Joseph M. Burnett as trustee of the trust."}],"balance_after":217359,"source":{"system":"sec-edgar","filing":"0001193125-25-239077","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000119312525239077/ownership.xml","form_type":"4"}},{"id":1019130,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":2368,"kind":"person","name":"BURNETT JOSEPH","position":1,"cik":"0001721010","reported_name":"BURNETT JOSEPH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2025-10-14T20:33:00.000Z","date":"2025-10-10","kind":"sale","planned":true,"acquired":false,"shares":6599,"price":27.64,"value":182396.36,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of shares reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on June 11, 2025 in accordance with Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents a weighted average sales price per share. The shares were sold at prices ranging from $27.08 to $28.07. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are owned directly by the Joseph M. Burnett Trust dated 10/20/2022 and indirectly by Joseph M. Burnett as trustee of the trust."}],"balance_after":219340,"source":{"system":"sec-edgar","filing":"0001193125-25-239077","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000119312525239077/ownership.xml","form_type":"4"}},{"id":1019129,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":2368,"kind":"person","name":"BURNETT JOSEPH","position":1,"cik":"0001721010","reported_name":"BURNETT JOSEPH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2025-10-14T20:33:00.000Z","date":"2025-10-10","kind":"sale","planned":true,"acquired":false,"shares":17583,"price":26.51,"value":466125.33,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of shares reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on June 11, 2025 in accordance with Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average sales price per share. The shares were sold at prices ranging from $26.07 to $27.06. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are owned directly by the Joseph M. Burnett Trust dated 10/20/2022 and indirectly by Joseph M. Burnett as trustee of the trust."}],"balance_after":225939,"source":{"system":"sec-edgar","filing":"0001193125-25-239077","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000119312525239077/ownership.xml","form_type":"4"}},{"id":1094679,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":2368,"kind":"person","name":"BURNETT JOSEPH","position":1,"cik":"0001721010","reported_name":"BURNETT JOSEPH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2025-07-02T21:05:51.000Z","date":"2025-06-30","kind":"grant","planned":false,"acquired":true,"shares":1424,"price":10.15,"value":14453.6,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of the Issuer's common stock pursuant to the Employee Stock Purchase Plan (\"ESPP\"), for the ESPP purchase period of January 1, 2025 through June 30, 2025. In accordance with the ESPP, these shares were purchased at the lesser of 85% of the fair market value on either the first day or last day of the purchase period."}],"balance_after":11311,"source":{"system":"sec-edgar","filing":"0000950170-25-093159","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000095017025093159/ownership.xml","form_type":"4"}},{"id":1113131,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":2368,"kind":"person","name":"BURNETT JOSEPH","position":1,"cik":"0001721010","reported_name":"BURNETT JOSEPH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2025-06-12T23:11:46.000Z","date":"2025-06-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":15476,"price":13.29,"value":205676.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the amount of shares delivered to CLPT to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":9887,"source":{"system":"sec-edgar","filing":"0000950170-25-085700","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000095017025085700/ownership.xml","form_type":"4"}},{"id":1114772,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":2368,"kind":"person","name":"BURNETT JOSEPH","position":1,"cik":"0001721010","reported_name":"BURNETT JOSEPH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2025-06-12T01:50:33.000Z","date":"2025-06-09","kind":"sale","planned":false,"acquired":false,"shares":21247,"price":13.29,"value":282372.63,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale of shares is incident to the net share settlement of 21,247 shares which vested on March 6, 2025 under a restricted stock unit granted to the reporting person on March 6, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average sales price per share. The shares were sold at prices ranging from $13.20 to $13.51. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are owned directly by the Joseph M. Burnett Trust dated 10/20/2022 and indirectly by Joseph M. Burnett as trustee of the trust."}],"balance_after":243522,"source":{"system":"sec-edgar","filing":"0000950170-25-085074","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000095017025085074/ownership.xml","form_type":"4"}},{"id":1205556,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":2368,"kind":"person","name":"BURNETT JOSEPH","position":1,"cik":"0001721010","reported_name":"BURNETT JOSEPH MICHAEL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Restricted Stock Units","published_at":"2025-03-14T20:33:00.000Z","date":"2025-03-12","kind":"exercise","planned":false,"acquired":false,"shares":42414,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. (\"CLPT\") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. (\"CLPT\") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. (\"CLPT\") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. (\"CLPT\") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."}],"balance_after":169657,"derivative":{"underlying":"Common Stock","underlying_shares":42414},"source":{"system":"sec-edgar","filing":"0000950170-25-039492","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000095017025039492/ownership.xml","form_type":"4"}},{"id":1205555,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":2368,"kind":"person","name":"BURNETT JOSEPH","position":1,"cik":"0001721010","reported_name":"BURNETT JOSEPH MICHAEL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2025-03-14T20:33:00.000Z","date":"2025-03-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":23405,"price":13.18,"value":308477.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the amount of shares delivered to CLPT to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":290132,"source":{"system":"sec-edgar","filing":"0000950170-25-039492","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000095017025039492/ownership.xml","form_type":"4"}},{"id":1205554,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":2368,"kind":"person","name":"BURNETT JOSEPH","position":1,"cik":"0001721010","reported_name":"BURNETT JOSEPH MICHAEL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2025-03-14T20:33:00.000Z","date":"2025-03-12","kind":"exercise","planned":false,"acquired":true,"shares":42414,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. (\"CLPT\") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."}],"balance_after":313537,"source":{"system":"sec-edgar","filing":"0000950170-25-039492","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000095017025039492/ownership.xml","form_type":"4"}},{"id":1214879,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":2368,"kind":"person","name":"BURNETT JOSEPH","position":1,"cik":"0001721010","reported_name":"BURNETT JOSEPH MICHAEL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Restricted Stock Units","published_at":"2025-03-10T23:44:41.000Z","date":"2025-03-06","kind":"exercise","planned":false,"acquired":false,"shares":47407,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. (\"CLPT\") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. (\"CLPT\") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. (\"CLPT\") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. (\"CLPT\") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."}],"balance_after":47407,"derivative":{"underlying":"Common Stock","underlying_shares":47407},"source":{"system":"sec-edgar","filing":"0000950170-25-036671","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000095017025036671/ownership.xml","form_type":"4"}},{"id":1214878,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":2368,"kind":"person","name":"BURNETT JOSEPH","position":1,"cik":"0001721010","reported_name":"BURNETT JOSEPH MICHAEL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2025-03-10T23:44:41.000Z","date":"2025-03-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":26160,"price":13.19,"value":345050.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the amount of shares delivered to CLPT to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":271123,"source":{"system":"sec-edgar","filing":"0000950170-25-036671","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000095017025036671/ownership.xml","form_type":"4"}},{"id":1214877,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":2368,"kind":"person","name":"BURNETT JOSEPH","position":1,"cik":"0001721010","reported_name":"BURNETT JOSEPH MICHAEL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2025-03-10T23:44:41.000Z","date":"2025-03-06","kind":"exercise","planned":false,"acquired":true,"shares":47407,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. (\"CLPT\") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."}],"balance_after":297283,"source":{"system":"sec-edgar","filing":"0000950170-25-036671","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000095017025036671/ownership.xml","form_type":"4"}},{"id":1227440,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":2368,"kind":"person","name":"BURNETT JOSEPH","position":1,"cik":"0001721010","reported_name":"BURNETT JOSEPH MICHAEL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Restricted Stock Units","published_at":"2025-03-04T22:00:49.000Z","date":"2025-03-03","kind":"grant","planned":false,"acquired":true,"shares":132841,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CLPT common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest as follows: (i) 20% of the total shares on March 3, 2026; (ii) 40% of the total shares on March 3, 2027; and (iii) 40% of the total shares on March 3, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest as follows: (i) 20% of the total shares on March 3, 2026; (ii) 40% of the total shares on March 3, 2027; and (iii) 40% of the total shares on March 3, 2028."}],"balance_after":132841,"derivative":{"underlying":"Common Stock","underlying_shares":132841},"source":{"system":"sec-edgar","filing":"0000950170-25-032365","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000095017025032365/ownership.xml","form_type":"4"}},{"id":1314132,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":2368,"kind":"person","name":"BURNETT JOSEPH","position":1,"cik":"0001721010","reported_name":"BURNETT JOSEPH MICHAEL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2025-01-03T22:19:32.000Z","date":"2024-12-31","kind":"grant","planned":false,"acquired":true,"shares":251,"price":4.53,"value":1137.03,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of the Issuer's common stock pursuant to the Employee Stock Purchase Plan (\"ESPP\"), for the ESPP purchase period of July 1, 2024 through December 31, 2024. In accordance with the ESPP, these shares were purchased at the lesser of 85% of the fair market value on either the first day or last day of the purchase period."}],"balance_after":249876,"source":{"system":"sec-edgar","filing":"0000950170-25-001356","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000095017025001356/ownership.xml","form_type":"4"}},{"id":1426428,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":2368,"kind":"person","name":"BURNETT JOSEPH","position":1,"cik":"0001721010","reported_name":"BURNETT JOSEPH MICHAEL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2024-08-21T20:18:10.000Z","date":"2024-08-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":3236,"price":11.26,"value":36437.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":249625,"source":{"system":"sec-edgar","filing":"0001285550-24-000102","document":"wk-form4_1724271484.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000128555024000102/wk-form4_1724271484.xml","form_type":"4"}},{"id":1462501,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":2368,"kind":"person","name":"BURNETT JOSEPH","position":1,"cik":"0001721010","reported_name":"BURNETT JOSEPH MICHAEL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2024-07-02T21:25:33.000Z","date":"2024-06-28","kind":"grant","planned":false,"acquired":true,"shares":3500,"price":4.58,"value":16030.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of the Issuer's common stock pursuant to the Employee Stock Purchase Plan (\"ESPP\"), for the ESPP purchase period of January 1, 2024 through June 30, 2024. In accordance with the ESPP, these shares were purchased at the lesser of 85% of the fair market value on either the first day or last day of the purchase period."}],"balance_after":252861,"source":{"system":"sec-edgar","filing":"0001285550-24-000089","document":"wk-form4_1719955526.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000128555024000089/wk-form4_1719955526.xml","form_type":"4"}},{"id":1483253,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":2368,"kind":"person","name":"BURNETT JOSEPH","position":1,"cik":"0001721010","reported_name":"BURNETT JOSEPH MICHAEL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2024-06-11T23:31:50.000Z","date":"2024-06-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":14003,"price":5.74,"value":80377.22,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":249361,"source":{"system":"sec-edgar","filing":"0001285550-24-000080","document":"wk-form4_1718148703.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000128555024000080/wk-form4_1718148703.xml","form_type":"4"}},{"id":1505274,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":2368,"kind":"person","name":"BURNETT JOSEPH","position":1,"cik":"0001721010","reported_name":"BURNETT JOSEPH MICHAEL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Restricted Stock Units","published_at":"2024-05-22T20:38:16.000Z","date":"2024-05-20","kind":"grant","planned":false,"acquired":true,"shares":212071,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CLPT common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest as follows: (i) 20% of the total shares on March 12, 2025; (ii) 40% of the total shares on March 12, 2026; and (iii) 40% of the total shares on March 12, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest as follows: (i) 20% of the total shares on March 12, 2025; (ii) 40% of the total shares on March 12, 2026; and (iii) 40% of the total shares on March 12, 2027."}],"balance_after":212071,"derivative":{"underlying":"Common Stock","underlying_shares":212071},"source":{"system":"sec-edgar","filing":"0001285550-24-000073","document":"wk-form4_1716410286.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000128555024000073/wk-form4_1716410286.xml","form_type":"4"}},{"id":1586400,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":2368,"kind":"person","name":"BURNETT JOSEPH","position":1,"cik":"0001721010","reported_name":"BURNETT JOSEPH MICHAEL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Restricted Stock Units","published_at":"2024-03-08T21:39:32.000Z","date":"2024-03-06","kind":"exercise","planned":false,"acquired":false,"shares":23704,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CLPT common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CLPT common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CLPT common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CLPT common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date."}],"balance_after":94814,"derivative":{"underlying":"Common Stock","underlying_shares":23704},"source":{"system":"sec-edgar","filing":"0001285550-24-000023","document":"wk-form4_1709933958.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000128555024000023/wk-form4_1709933958.xml","form_type":"4"}},{"id":1586399,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":2368,"kind":"person","name":"BURNETT JOSEPH","position":1,"cik":"0001721010","reported_name":"BURNETT JOSEPH MICHAEL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2024-03-08T21:39:32.000Z","date":"2024-03-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":11066,"price":6.24,"value":69051.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":263364,"source":{"system":"sec-edgar","filing":"0001285550-24-000023","document":"wk-form4_1709933958.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000128555024000023/wk-form4_1709933958.xml","form_type":"4"}},{"id":1586398,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":2368,"kind":"person","name":"BURNETT JOSEPH","position":1,"cik":"0001721010","reported_name":"BURNETT JOSEPH MICHAEL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2024-03-08T21:39:32.000Z","date":"2024-03-06","kind":"exercise","planned":false,"acquired":true,"shares":23704,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":274430,"source":{"system":"sec-edgar","filing":"0001285550-24-000023","document":"wk-form4_1709933958.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000128555024000023/wk-form4_1709933958.xml","form_type":"4"}},{"id":1691614,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":2368,"kind":"person","name":"BURNETT JOSEPH","position":1,"cik":"0001721010","reported_name":"BURNETT JOSEPH MICHAEL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2024-01-04T01:51:06.000Z","date":"2023-12-29","kind":"grant","planned":false,"acquired":true,"shares":1067,"price":5.77,"value":6156.59,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of the Issuer's common stock pursuant to the Employee Stock Purchase Plan (\"ESPP\"), for the ESPP purchase period of July 1, 2023 through December 31, 2023. In accordance with the ESPP, these shares were purchased at the lesser of 85% of the fair market value on either the first business day or last business day of the purchase period."}],"balance_after":250726,"source":{"system":"sec-edgar","filing":"0001285550-24-000011","document":"wk-form4_1704333050.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000128555024000011/wk-form4_1704333050.xml","form_type":"4"}},{"id":1831542,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":2368,"kind":"person","name":"BURNETT JOSEPH","position":1,"cik":"0001721010","reported_name":"BURNETT JOSEPH MICHAEL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2023-07-11T20:32:04.000Z","date":"2023-07-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":6122,"price":6.58,"value":40282.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":249659,"source":{"system":"sec-edgar","filing":"0001285550-23-000088","document":"wf-form4_168910751319479.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000128555023000088/wf-form4_168910751319479.xml","form_type":"4"}},{"id":1835652,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":2368,"kind":"person","name":"BURNETT JOSEPH","position":1,"cik":"0001721010","reported_name":"BURNETT JOSEPH MICHAEL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2023-07-05T21:47:51.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":2095,"price":6.15,"value":12884.25,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of the Issuer's common stock pursuant to the Employee Stock Purchase Plan (\"ESPP\"), for the ESPP purchase period of January 1, 2023 through June 30, 2023. In accordance with the ESPP, these shares were purchased at the lesser of 85% of the fair market value on either the first day or last day of the purchase period."}],"balance_after":255781,"source":{"system":"sec-edgar","filing":"0001285550-23-000084","document":"wf-form4_168859366246419.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000128555023000084/wf-form4_168859366246419.xml","form_type":"4"}},{"id":1857078,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":2368,"kind":"person","name":"BURNETT JOSEPH","position":1,"cik":"0001721010","reported_name":"BURNETT JOSEPH MICHAEL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2023-06-13T21:02:51.000Z","date":"2023-06-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":6952,"price":6.91,"value":48038.32,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":253686,"source":{"system":"sec-edgar","filing":"0001285550-23-000070","document":"wf-form4_168669014858066.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000128555023000070/wf-form4_168669014858066.xml","form_type":"4"}},{"id":1963019,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":2368,"kind":"person","name":"BURNETT JOSEPH","position":1,"cik":"0001721010","reported_name":"BURNETT JOSEPH MICHAEL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Restricted Stock Units","published_at":"2023-03-08T21:51:55.000Z","date":"2023-03-06","kind":"grant","acquired":true,"shares":118518,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CLPT common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest as follows: (i) 20% of the total shares on the first anniversary of the grant date; (ii) 40% of the total shares on the second anniversary of the grant date; and (iii) 40% of the total shares on the third anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest as follows: (i) 20% of the total shares on the first anniversary of the grant date; (ii) 40% of the total shares on the second anniversary of the grant date; and (iii) 40% of the total shares on the third anniversary of the grant date."}],"balance_after":118518,"derivative":{"underlying":"Common Stock","underlying_shares":118518},"source":{"system":"sec-edgar","filing":"0001285550-23-000030","document":"wf-form4_167831230569599.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000128555023000030/wf-form4_167831230569599.xml","form_type":"4"}},{"id":1963018,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":2368,"kind":"person","name":"BURNETT JOSEPH","position":1,"cik":"0001721010","reported_name":"BURNETT JOSEPH MICHAEL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Stock Options (right to buy)","published_at":"2023-03-08T21:51:55.000Z","date":"2023-03-06","kind":"grant","acquired":true,"shares":39506,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option vest as follows: (i) 20% of the total shares on the first anniversary of the grant date; (ii) 40% of the total shares on the second anniversary of the grant date; and (iii) 40% of the total shares on the third anniversary of the grant date."}],"balance_after":39506,"derivative":{"exercise_price":8.1,"expiration_date":"2033-03-06","underlying":"Common Stock","underlying_shares":39506},"source":{"system":"sec-edgar","filing":"0001285550-23-000030","document":"wf-form4_167831230569599.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000128555023000030/wf-form4_167831230569599.xml","form_type":"4"}},{"id":2175990,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":2368,"kind":"person","name":"BURNETT JOSEPH","position":1,"cik":"0001721010","reported_name":"BURNETT JOSEPH MICHAEL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2022-08-23T22:13:20.000Z","date":"2022-08-20","kind":"tax_withholding","acquired":false,"shares":1457,"price":13.24,"value":19290.68,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":260638,"source":{"system":"sec-edgar","filing":"0001285550-22-000051","document":"wf-form4_166129278397329.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000128555022000051/wf-form4_166129278397329.xml","form_type":"4"}},{"id":2183933,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":2368,"kind":"person","name":"BURNETT JOSEPH","position":1,"cik":"0001721010","reported_name":"BURNETT JOSEPH MICHAEL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2022-08-16T20:47:29.000Z","date":"2022-08-15","kind":"sale","acquired":false,"shares":18867,"price":16.07,"value":303192.69,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":262095,"source":{"system":"sec-edgar","filing":"0001285550-22-000045","document":"wf-form4_166068282013601.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000128555022000045/wf-form4_166068282013601.xml","form_type":"4"}},{"id":2183932,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":2368,"kind":"person","name":"BURNETT JOSEPH","position":1,"cik":"0001721010","reported_name":"BURNETT JOSEPH MICHAEL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2022-08-16T20:47:29.000Z","date":"2022-08-15","kind":"tax_withholding","acquired":false,"shares":7778,"price":16.02,"value":124603.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,155 shares of common stock acquired through purchases pursuant to the Employee Stock Purchase Plan."}],"balance_after":280962,"source":{"system":"sec-edgar","filing":"0001285550-22-000045","document":"wf-form4_166068282013601.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000128555022000045/wf-form4_166068282013601.xml","form_type":"4"}},{"id":2208513,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":2368,"kind":"person","name":"BURNETT JOSEPH","position":1,"cik":"0001721010","reported_name":"BURNETT JOSEPH MICHAEL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2022-07-12T23:04:12.000Z","date":"2022-07-09","kind":"tax_withholding","acquired":false,"shares":6664,"price":14.24,"value":94895.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":286585,"source":{"system":"sec-edgar","filing":"0001285550-22-000036","document":"wf-form4_165766703828158.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000128555022000036/wf-form4_165766703828158.xml","form_type":"4"}},{"id":2232481,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":2368,"kind":"person","name":"BURNETT JOSEPH","position":1,"cik":"0001721010","reported_name":"BURNETT JOSEPH MICHAEL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Stock Options (right to buy)","published_at":"2022-06-14T20:15:24.000Z","date":"2022-06-10","kind":"grant","acquired":true,"shares":46742,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to this option vest as follows: (i) 20% of the total shares on the first anniversary of the grant date; (ii) 40% of the total shares on the second anniversary of the grant date; and (iii) 40% of the total shares on the third anniversary of the grant date."}],"balance_after":46742,"derivative":{"exercise_price":11.41,"expiration_date":"2032-06-10","underlying":"Common Stock","underlying_shares":46742},"source":{"system":"sec-edgar","filing":"0001285550-22-000023","document":"wf-form4_165523769683678.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000128555022000023/wf-form4_165523769683678.xml","form_type":"4"}},{"id":2232480,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":2368,"kind":"person","name":"BURNETT JOSEPH","position":1,"cik":"0001721010","reported_name":"BURNETT JOSEPH MICHAEL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2022-06-14T20:15:24.000Z","date":"2022-06-10","kind":"grant","acquired":true,"shares":70113,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares are restricted stock and vest as follows: (i) 20% of the total shares on the first anniversary of the grant date; (ii) 40% of the total shares on the second anniversary of the grant date; and (iii) 40% of the total shares on the third anniversary of the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,349 shares of common stock acquired through purchases pursuant to the Employee Stock Purchase Plan."}],"balance_after":293249,"source":{"system":"sec-edgar","filing":"0001285550-22-000023","document":"wf-form4_165523769683678.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000128555022000023/wf-form4_165523769683678.xml","form_type":"4"}},{"id":2514728,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":2368,"kind":"person","name":"BURNETT JOSEPH","position":1,"cik":"0001721010","reported_name":"BURNETT JOSEPH MICHAEL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2021-11-12T21:46:28.000Z","date":"2021-11-11","kind":"sale","acquired":false,"shares":10000,"price":16.88,"value":168800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":221787,"source":{"system":"sec-edgar","filing":"0001420506-21-001558","document":"doc4_978.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000142050621001558/doc4_978.xml","form_type":"4"}},{"id":2562954,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":2368,"kind":"person","name":"BURNETT JOSEPH","position":1,"cik":"0001721010","reported_name":"BURNETT JOSEPH MICHAEL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2021-09-21T20:40:30.000Z","date":"2021-09-21","kind":"sale","acquired":false,"shares":9637,"price":17.98,"value":173273.26,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":231787,"source":{"system":"sec-edgar","filing":"0001420506-21-001352","document":"doc4_967.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000142050621001352/doc4_967.xml","form_type":"4"}},{"id":2593455,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":2368,"kind":"person","name":"BURNETT JOSEPH","position":1,"cik":"0001721010","reported_name":"BURNETT JOSEPH MICHAEL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Stock Options (right to buy)","published_at":"2021-08-23T20:07:28.000Z","date":"2021-08-20","kind":"grant","acquired":true,"shares":29377,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option vest as follows: (i) 20% of the total shares on the first anniversary of the grant date; (ii) 40% of the total shares on the second anniversary of the grant date; and (iii) 40% of the total shares on the third anniversary of the grant date."}],"balance_after":29377,"derivative":{"exercise_price":16.71,"expiration_date":"2031-08-20","underlying":"Common Stock","underlying_shares":29377},"source":{"system":"sec-edgar","filing":"0001420506-21-001337","document":"doc4_963.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000142050621001337/doc4_963.xml","form_type":"4"}},{"id":2593454,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":2368,"kind":"person","name":"BURNETT JOSEPH","position":1,"cik":"0001721010","reported_name":"BURNETT JOSEPH MICHAEL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2021-08-23T20:07:28.000Z","date":"2021-08-20","kind":"grant","acquired":true,"shares":14688,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares are restricted stock and vest as follows: (i) 20% of the total shares on the first anniversary of the grant date; (ii) 40% of the total shares on the second anniversary of the grant date; and (iii) 40% of the total shares on the third anniversary of the grant date."}],"balance_after":241424,"source":{"system":"sec-edgar","filing":"0001420506-21-001337","document":"doc4_963.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000142050621001337/doc4_963.xml","form_type":"4"}},{"id":2599776,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":2368,"kind":"person","name":"BURNETT JOSEPH","position":1,"cik":"0001721010","reported_name":"BURNETT JOSEPH MICHAEL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2021-08-17T21:07:26.000Z","date":"2021-08-15","kind":"tax_withholding","acquired":false,"shares":7353,"price":17.7,"value":130148.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the vesting of shares\nof restricted stock."}],"balance_after":226736,"source":{"system":"sec-edgar","filing":"0001420506-21-001323","document":"doc4_957.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000142050621001323/doc4_957.xml","form_type":"4"}},{"id":2634748,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":2368,"kind":"person","name":"BURNETT JOSEPH","position":1,"cik":"0001721010","reported_name":"BURNETT JOSEPH MICHAEL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2021-07-13T20:11:50.000Z","date":"2021-07-09","kind":"tax_withholding","acquired":false,"shares":3277,"price":18.54,"value":60755.58,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":234089,"source":{"system":"sec-edgar","filing":"0001420506-21-000869","document":"doc4_949.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000142050621000869/doc4_949.xml","form_type":"4"}},{"id":2658629,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":2368,"kind":"person","name":"BURNETT JOSEPH","position":1,"cik":"0001721010","reported_name":"BURNETT JOSEPH MICHAEL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2021-06-22T22:49:07.000Z","date":"2021-06-21","kind":"sale","acquired":false,"shares":25000,"price":18.57,"value":464250.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":237366,"source":{"system":"sec-edgar","filing":"0001420506-21-000838","document":"doc4_935.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000142050621000838/doc4_935.xml","form_type":"4"}},{"id":2919980,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":2368,"kind":"person","name":"BURNETT JOSEPH","position":1,"cik":"0001721010","reported_name":"BURNETT JOSEPH MICHAEL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2021-01-05T21:04:05.000Z","date":"2020-11-07","kind":"tax_withholding","acquired":false,"shares":5765,"price":6.65,"value":38337.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This amendment on Form 4/A to the original Form 4 filed on November 7, 2020 is made solely to correct the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted"}],"balance_after":262366,"source":{"system":"sec-edgar","filing":"0001420506-21-000014","document":"doc4a_900.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000142050621000014/doc4a_900.xml","form_type":"4/A","original_submission_date":"2020-11-07"}},{"id":2988122,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":2368,"kind":"person","name":"BURNETT JOSEPH","position":1,"cik":"0001721010","reported_name":"BURNETT JOSEPH MICHAEL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2020-11-09T21:13:05.000Z","date":"2020-11-07","kind":"tax_withholding","acquired":false,"shares":14286,"price":6.65,"value":95001.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":253845,"source":{"system":"sec-edgar","filing":"0001420506-20-001168","document":"doc4_881.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000142050620001168/doc4_881.xml","form_type":"4"}},{"id":3053805,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":2368,"kind":"person","name":"BURNETT JOSEPH","position":1,"cik":"0001721010","reported_name":"BURNETT JOSEPH MICHAEL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2020-08-18T20:26:23.000Z","date":"2020-08-15","kind":"tax_withholding","acquired":false,"shares":2491,"price":4.1,"value":10213.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":268131,"source":{"system":"sec-edgar","filing":"0001420506-20-000996","document":"doc4_841.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000142050620000996/doc4_841.xml","form_type":"4"}},{"id":3063328,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":2368,"kind":"person","name":"BURNETT JOSEPH","position":1,"cik":"0001721010","reported_name":"BURNETT JOSEPH MICHAEL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2020-08-10T20:09:12.000Z","date":"2020-08-07","kind":"tax_withholding","acquired":false,"shares":5763,"price":4,"value":23052.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":270622,"source":{"system":"sec-edgar","filing":"0001420506-20-000853","document":"doc4_840.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000142050620000853/doc4_840.xml","form_type":"4"}},{"id":3084244,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":2368,"kind":"person","name":"BURNETT JOSEPH","position":1,"cik":"0001721010","reported_name":"BURNETT JOSEPH MICHAEL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Stock Options (right to buy)","published_at":"2020-07-13T20:07:27.000Z","date":"2020-07-09","kind":"grant","acquired":true,"shares":52356,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option vest as follows: (i) 20% of the total shares on the first anniversary of the grant date; (ii) 40% of the total shares on the second anniversary of the grant date; and (iii) 40% of the total shares on the third anniversary of the grant date."}],"balance_after":52356,"derivative":{"exercise_price":3.24,"expiration_date":"2030-07-09","underlying":"Common Stock","underlying_shares":52356},"source":{"system":"sec-edgar","filing":"0001420506-20-000713","document":"doc4_828.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000142050620000713/doc4_828.xml","form_type":"4"}},{"id":3084243,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":2368,"kind":"person","name":"BURNETT JOSEPH","position":1,"cik":"0001721010","reported_name":"BURNETT JOSEPH MICHAEL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2020-07-13T20:07:27.000Z","date":"2020-07-09","kind":"grant","acquired":true,"shares":30864,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares are restricted stock and vest as follows: (i) 20% of the total shares on the first anniversary of the grant date; (ii) 40% of the total shares on the second anniversary of the grant date; and (iii) 40% of the total shares on the third anniversary of the grant date."}],"balance_after":276385,"source":{"system":"sec-edgar","filing":"0001420506-20-000713","document":"doc4_828.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000142050620000713/doc4_828.xml","form_type":"4"}},{"id":3156194,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":2368,"kind":"person","name":"BURNETT JOSEPH","position":1,"cik":"0001721010","reported_name":"BURNETT JOSEPH MICHAEL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2020-05-08T23:00:52.000Z","date":"2020-05-07","kind":"tax_withholding","acquired":false,"shares":6627,"price":3.69,"value":24453.63,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock"}],"balance_after":245521,"source":{"system":"sec-edgar","filing":"0001420506-20-000473","document":"doc4_801.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000142050620000473/doc4_801.xml","form_type":"4"}},{"id":3279535,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":2368,"kind":"person","name":"BURNETT JOSEPH","position":1,"cik":"0001721010","reported_name":"BURNETT JOSEPH MICHAEL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2020-02-11T14:29:15.000Z","date":"2020-02-07","kind":"tax_withholding","acquired":false,"shares":5590,"price":5.3,"value":29627.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock"}],"balance_after":252148,"source":{"system":"sec-edgar","filing":"0001420506-20-000135","document":"doc4_786.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000142050620000135/doc4_786.xml","form_type":"4"}},{"id":3374263,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":2368,"kind":"person","name":"BURNETT JOSEPH","position":1,"cik":"0001721010","reported_name":"BURNETT JOSEPH MICHAEL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2019-11-12T13:40:46.000Z","date":"2019-11-07","kind":"tax_withholding","acquired":false,"shares":5590,"price":3.87,"value":21633.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":257738,"source":{"system":"sec-edgar","filing":"0001534424-19-000301","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000153442419000301/ownership.xml","form_type":"4"}},{"id":3434290,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":2368,"kind":"person","name":"BURNETT JOSEPH","position":1,"cik":"0001721010","reported_name":"BURNETT JOSEPH MICHAEL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Stock Options (right to buy)","published_at":"2019-08-19T20:05:26.000Z","date":"2019-08-15","kind":"grant","acquired":true,"shares":74404,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option vest as follows: (i) 20% of the total shares on the first anniversary of the grant date; (ii) 40% of the total shares on the second anniversary of the grant date; and (iii) 40% of the total shares on the third anniversary of the grant date."}],"balance_after":74404,"derivative":{"exercise_price":3.47,"expiration_date":"2029-08-15","underlying":"Common Stock","underlying_shares":74404},"source":{"system":"sec-edgar","filing":"0001534424-19-000241","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000153442419000241/ownership.xml","form_type":"4"}},{"id":3434289,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":2368,"kind":"person","name":"BURNETT JOSEPH","position":1,"cik":"0001721010","reported_name":"BURNETT JOSEPH MICHAEL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2019-08-19T20:05:26.000Z","date":"2019-08-15","kind":"grant","acquired":true,"shares":36023,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares are restricted stock and vest as follows: (i) 20% of the total shares on the first anniversary of the grant date; (ii) 40% of the total shares on the second anniversary of the grant date; and (iii) 40% of the total shares on the third anniversary of the grant date."}],"balance_after":263328,"source":{"system":"sec-edgar","filing":"0001534424-19-000241","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000153442419000241/ownership.xml","form_type":"4"}},{"id":3443408,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":2368,"kind":"person","name":"BURNETT JOSEPH","position":1,"cik":"0001721010","reported_name":"BURNETT JOSEPH MICHAEL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2019-08-08T20:05:19.000Z","date":"2019-08-07","kind":"tax_withholding","acquired":false,"shares":5590,"price":4.26,"value":23813.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":227305,"source":{"system":"sec-edgar","filing":"0001534424-19-000227","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000153442419000227/ownership.xml","form_type":"4"}},{"id":3534986,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":2368,"kind":"person","name":"BURNETT JOSEPH","position":1,"cik":"0001721010","reported_name":"BURNETT JOSEPH MICHAEL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2019-05-08T20:28:58.000Z","date":"2019-05-07","kind":"tax_withholding","acquired":false,"shares":5590,"price":3.1,"value":17329.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":232895,"source":{"system":"sec-edgar","filing":"0001534424-19-000132","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000153442419000132/ownership.xml","form_type":"4"}},{"id":3628779,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":2368,"kind":"person","name":"BURNETT JOSEPH","position":1,"cik":"0001721010","reported_name":"BURNETT JOSEPH MICHAEL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2019-02-27T21:05:33.000Z","date":"2018-11-07","kind":"tax_withholding","acquired":false,"shares":23053,"price":2,"value":46106.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":238485,"source":{"system":"sec-edgar","filing":"0001534424-19-000069","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000153442419000069/ownership.xml","form_type":"4"}},{"id":3665703,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":2368,"kind":"person","name":"BURNETT JOSEPH","position":1,"cik":"0001721010","reported_name":"BURNETT JOSEPH MICHAEL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2019-02-11T21:05:17.000Z","date":"2019-02-07","kind":"tax_withholding","acquired":false,"shares":6475,"price":2.75,"value":17806.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock."}],"balance_after":261538,"source":{"system":"sec-edgar","filing":"0001534424-19-000064","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000153442419000064/ownership.xml","form_type":"4"}},{"id":3686701,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":2368,"kind":"person","name":"BURNETT JOSEPH","position":1,"cik":"0001721010","reported_name":"BURNETT JOSEPH MICHAEL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2019-01-25T21:55:45.000Z","date":"2019-01-23","kind":"tax_withholding","acquired":false,"shares":8304,"price":2.55,"value":21175.2,"ownership":{"direct":true},"balance_after":268013,"source":{"system":"sec-edgar","filing":"0001534424-19-000045","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000153442419000045/ownership.xml","form_type":"4"}},{"id":3686700,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":2368,"kind":"person","name":"BURNETT JOSEPH","position":1,"cik":"0001721010","reported_name":"BURNETT JOSEPH MICHAEL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2019-01-25T21:55:45.000Z","date":"2019-01-23","kind":"grant","acquired":true,"shares":20313,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person received a portion of his 2018 cash bonus in the form of the Company's common stock based on the closing sales price of the Company's common stock on January 23, 2019. The shares were granted under the Company's Second Amended and Restated 2013 Incentive Compensation Plan."}],"balance_after":276317,"source":{"system":"sec-edgar","filing":"0001534424-19-000045","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000153442419000045/ownership.xml","form_type":"4"}},{"id":3808145,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":2368,"kind":"person","name":"BURNETT JOSEPH","position":1,"cik":"0001721010","reported_name":"BURNETT JOSEPH MICHAEL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-09-25T21:23:38.000Z","date":"2018-09-25","kind":"purchase","acquired":true,"shares":25000,"price":1.25,"value":31250.0,"ownership":{"direct":true},"balance_after":256004,"source":{"system":"sec-edgar","filing":"0001534424-18-000318","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000153442418000318/ownership.xml","form_type":"4"}},{"id":3833706,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":2368,"kind":"person","name":"BURNETT JOSEPH","position":1,"cik":"0001721010","reported_name":"BURNETT JOSEPH MICHAEL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-08-24T20:05:29.000Z","date":"2018-08-24","kind":"purchase","acquired":true,"shares":7500,"price":1.58,"value":11850.0,"ownership":{"direct":true},"balance_after":238504,"source":{"system":"sec-edgar","filing":"0001534424-18-000288","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000153442418000288/ownership.xml","form_type":"4"}},{"id":3833705,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":2368,"kind":"person","name":"BURNETT JOSEPH","position":1,"cik":"0001721010","reported_name":"BURNETT JOSEPH MICHAEL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-08-24T20:05:29.000Z","date":"2018-08-22","kind":"purchase","acquired":true,"shares":4637,"price":1.55,"value":7187.35,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This amount corrects a typographical error, which inadvertently overstated the reporting person's holdings, in the previously filed Form 4."}],"balance_after":231004,"source":{"system":"sec-edgar","filing":"0001534424-18-000288","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000153442418000288/ownership.xml","form_type":"4"}},{"id":3920269,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":2368,"kind":"person","name":"BURNETT JOSEPH","position":1,"cik":"0001721010","reported_name":"BURNETT JOSEPH MICHAEL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-05-23T20:05:21.000Z","date":"2018-05-22","kind":"grant","acquired":true,"shares":18867,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person received the final $50,000 portion of his signing bonus in the form of the Company's common stock based on the closing price as of May 22, 2018. The shares were granted under the Company's Second Amended and Restated 2013 Incentive Compensation Plan."}],"balance_after":576367,"source":{"system":"sec-edgar","filing":"0001534424-18-000173","document":"burnett.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000153442418000173/burnett.xml","form_type":"4"}},{"id":3920268,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":2368,"kind":"person","name":"BURNETT JOSEPH","position":1,"cik":"0001721010","reported_name":"BURNETT JOSEPH MICHAEL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-05-23T20:05:21.000Z","date":"2018-05-21","kind":"purchase","acquired":true,"shares":7500,"price":2.387,"value":17902.5,"ownership":{"direct":true},"balance_after":557500,"source":{"system":"sec-edgar","filing":"0001534424-18-000173","document":"burnett.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000153442418000173/burnett.xml","form_type":"4"}},{"id":4170069,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":2368,"kind":"person","name":"BURNETT JOSEPH","position":1,"cik":"0001721010","reported_name":"BURNETT JOSEPH MICHAEL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Options (right to buy)","published_at":"2017-11-07T21:37:25.000Z","date":"2017-11-07","kind":"grant","acquired":true,"shares":350000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option vest as follows: (i) one-third of the total shares on the first anniversary of the grant date; and (ii) the remaining two-thirds of the total shares ratably on a quarterly basis over the 2-year period immediately following the first anniversary of the grant date."}],"balance_after":350000,"derivative":{"exercise_price":2.5,"expiration_date":"2027-11-07","underlying":"Common Stock","underlying_shares":350000},"source":{"system":"sec-edgar","filing":"0001534424-17-000461","document":"burnett.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000153442417000461/burnett.xml","form_type":"4"}},{"id":4170068,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":2368,"kind":"person","name":"BURNETT JOSEPH","position":1,"cik":"0001721010","reported_name":"BURNETT JOSEPH MICHAEL","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-11-07T21:37:25.000Z","date":"2017-11-07","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares are restricted stock and vest as follows: (i) one-third of the total shares on the first anniversary of the grant date; and (ii) the remaining two-thirds of the total shares ratably on a quarterly basis over the 2-year period immediately following the first anniversary of the grant date."}],"balance_after":200000,"source":{"system":"sec-edgar","filing":"0001534424-17-000461","document":"burnett.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1285550/000153442417000461/burnett.xml","form_type":"4"}}]}